Gilead Sciences Market Cap

Gilead Sciences has a market cap or net worth of €128.53 billion as of March 31, 2025. Its market cap has increased by 48.69% in one year.

Market Cap

128.53B

Enterprise Value

142.99B

Revenue

27.77B

Ranking

n/a

PE Ratio

277.21

Stock Price

€103.00

Market Cap Chart

Since January 22, 1992, Gilead Sciences's market cap has increased from 194.48M to 128.53B, an increase of 65,987.07%. That is a compound annual growth rate of 21.60%.

Market Cap History

Date	Market Cap	% Change
Mar 28, 2025	128.53B	15.59%
Dec 31, 2024	111.19B	21.76%
Dec 29, 2023	91.32B	-9.36%
Dec 30, 2022	100.75B	25.80%
Dec 31, 2021	80.09B	34.14%
Dec 31, 2020	59.70B	-18.50%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Merck KGaA	56.76B
Siemens Healthineers AG	56.75B
Fresenius SE & Co. KGaA	22.54B
Bayer Aktiengesellschaft	22.17B
Sartorius Aktiengesellschaft	13.70B
Fresenius Medical Care AG	13.48B
Carl Zeiss Meditec AG	5.75B
Fielmann Group AG	3.60B

Market Cap Rankings